Table of Contents
Advances in Biology
Volume 2014, Article ID 143023, 12 pages
http://dx.doi.org/10.1155/2014/143023
Review Article

GPCRs: Lipid-Dependent Membrane Receptors That Act as Drug Targets

CSIR-Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India

Received 20 July 2014; Accepted 6 September 2014; Published 2 October 2014

Academic Editor: Luis Loura

Copyright © 2014 Amitabha Chattopadhyay. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Pierce, R. T. Premont, and R. J. Lefkowitz, “Seven-transmembrane receptors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 9, pp. 639–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Perez, “The evolutionarily triumphant G-protein-coupled receptor,” Molecular Pharmacology, vol. 63, no. 6, pp. 1202–1205, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Rosenbaum, S. G. F. Rasmussen, and B. K. Kobilka, “The structure and function of G-protein-coupled receptors,” Nature, vol. 459, no. 7245, pp. 356–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Venkatakrishnan, X. Deupi, G. Lebon, C. G. Tate, G. F. Schertler, and M. Madan Babu, “Molecular signatures of G-protein-coupled receptors,” Nature, vol. 494, no. 7436, pp. 185–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Zhang, M. E. Devries, and J. Skolnick, “Structure modeling of all identified G protein-coupled receptors in the human genome,” PLoS Computational Biology, vol. 2, no. 2, article e13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Schöneberg, M. Hofreiter, A. Schulz, and H. Römpler, “Learning from the past: evolution of GPCR functions,” Trends in Pharmacological Sciences, vol. 28, no. 3, pp. 117–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Fredriksson, M. C. Lagerström, L.-G. Lundin, and H. B. Schiöth, “The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints,” Molecular Pharmacology, vol. 63, no. 6, pp. 1256–1272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Krishnan, M. S. Almén, R. Fredriksson, and H. B. Schiöth, “The origin of GPCRs: identification of mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in fungi,” PLoS ONE, vol. 7, no. 1, Article ID e29817, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Gether, “Uncovering molecular mechanisms involved in activation of G protein-coupled receptors,” Endocrine Reviews, vol. 21, no. 1, pp. 90–113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Ellis, “The state of GPCR research in 2004,” Nature Reviews. Drug Discovery, vol. 3, no. 7, pp. 577–626, 2004. View at Publisher · View at Google Scholar
  11. E. Jacoby, R. Bouhelal, M. Gerspacher, and K. Seuwen, “The 7TM G-protein-coupled receptor target family,” ChemMedChem, vol. 1, no. 8, pp. 760–782, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. Insel, C.-M. Tang, I. Hahntow, and M. C. Michel, “Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets,” Biochimica et Biophysica Acta, vol. 1768, no. 4, pp. 994–1005, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Heilker, M. Wolff, C. S. Tautermann, and M. Bieler, “G-protein-coupled receptor-focused drug discovery using a target class platform approach,” Drug Discovery Today, vol. 14, no. 5-6, pp. 231–240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Schlyer and R. Horuk, “I want a new drug: G-protein-coupled receptors in drug development,” Drug Discovery Today, vol. 11, no. 11-12, pp. 481–493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Thomsen, J. Frazer, and D. Unett, “Functional assays for screening GPCR targets,” Current Opinion in Biotechnology, vol. 16, no. 6, pp. 655–665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. H. S. Lin and O. Civelli, “Orphan G protein-coupled receptors: targets for new therapeutic interventions,” Annals of Medicine, vol. 36, no. 3, pp. 204–214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. B. L. Roth and F. H. Marshall, “NOBEL 2012 chemistry: studies of a ubiquitous receptor family,” Nature, vol. 491, article 57, no. 7427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Anson, “Membrane protein biophysics,” Nature, vol. 459, no. 7245, article 343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Deisenhofer, O. Epp, and K. Miki, “Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution,” Nature, vol. 318, no. 6047, pp. 618–624, 1985. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Deupi and B. K. Kobilka, “Energy landscapes as a tool to integrate GPCR structure, dynamics, and function,” Physiology, vol. 25, no. 5, pp. 293–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Audet and M. Bouvier, “Insights into signaling from the β2-adrenergic receptor structure,” Nature Chemical Biology, vol. 4, no. 7, pp. 397–403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Yao and B. Kobilka, “Using synthetic lipids to stabilize purified β2 adrenoceptor in detergent micelles,” Analytical Biochemistry, vol. 343, no. 2, pp. 344–346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. D. Paila, S. Tiwari, D. Sengupta, and A. Chattopadhyay, “Molecular modeling of the human serotonin1A receptor: role of membrane cholesterol in ligand binding of the receptor,” Molecular BioSystems, vol. 7, no. 1, pp. 224–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Saxena and A. Chattopadhyay, “Membrane cholesterol stabilizes the human serotonin1A receptor,” Biochimica et Biophysica Acta, vol. 1818, no. 12, pp. 2936–2942, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Nygaard, Y. Zou, R. O. Dror et al., “The dynamic process of β2-adrenergic receptor activation,” Cell, vol. 152, no. 3, pp. 532–542, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Schmidt, L. Thomas, P. Müller, H. A. Scheidt, and D. Huster, “The G-protein-coupled neuropeptide y receptor type 2 is highly dynamic in lipid membranes as revealed by solid-state NMR spectroscopy,” Chemistry, vol. 20, no. 17, pp. 4986–4992, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. D. F. Hansen, P. Vallurupalli, and L. E. Kay, “Using relaxation dispersion NMR spectroscopy to determine structures of excited, invisible protein states,” Journal of Biomolecular NMR, vol. 41, no. 3, pp. 113–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Cherezov, D. M. Rosenbaum, M. A. Hanson et al., “High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor,” Science, vol. 318, no. 5854, pp. 1258–1265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Hanson, V. Cherezov, M. T. Griffith et al., “A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor,” Structure, vol. 16, no. 6, pp. 897–905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. P. W. Day, S. G. F. Rasmussen, C. Parnot et al., “A monoclonal antibody for G protein-coupled receptor crystallography,” Nature Methods, vol. 4, no. 11, pp. 927–929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Rosenbaum, V. Cherezov, M. A. Hanson et al., “GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function,” Science, vol. 318, no. 5854, pp. 1266–1273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. G. F. Rasmussen, B. T. DeVree, Y. Zou et al., “Crystal structure of the β2 adrenergic receptor-Gs protein complex,” Nature, vol. 477, no. 7366, pp. 549–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Katritch, V. Cherezov, and R. C. Stevens, “Structure-function of the G protein-coupled receptor superfamily,” Annual Review of Pharmacology and Toxicology, vol. 53, pp. 531–556, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. H. Park, B. B. Das, F. Casagrande et al., “Structure of the chemokine receptor CXCR1 in phospholipid bilayers,” Nature, vol. 491, no. 7426, pp. 779–783, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Jafurulla, B. D. Rao, S. Sreedevi, J. M. Ruysschaert, D. F. Covey, and A. Chattopadhyay, “Stereospecific requirement of cholesterol in the function of the serotonin1A receptor,” Biochimica et Biophysica Acta, vol. 1838, no. 1, pp. 158–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Jafurulla and A. Chattopadhyay, “Membrane lipids in the function of serotonin and adrenergic receptors,” Current Medicinal Chemistry, vol. 20, no. 1, pp. 47–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Wu, C. Wang, K. J. Gregory et al., “Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator,” Science, vol. 344, no. 6179, pp. 58–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Jafurulla, S. Tiwari, and A. Chattopadhyay, “Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors,” Biochemical and Biophysical Research Communications, vol. 404, no. 1, pp. 569–573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Sengupta and A. Chattopadhyay, “Identification of cholesterol binding sites in the serotonin1A receptor,” Journal of Physical Chemistry B, vol. 116, no. 43, pp. 12991–12996, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Prasanna, A. Chattopadhyay, and D. Sengupta, “Cholesterol modulates the dimer interface of the β2- adrenergic receptor via cholesterol occupancy sites,” Biophysical Journal, vol. 106, no. 6, pp. 1290–1300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Burger, G. Gimpl, and F. Fahrenholz, “Regulation of receptor function by cholesterol,” Cellular and Molecular Life Sciences, vol. 57, no. 11, pp. 1577–1592, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. T. J. Pucadyil and A. Chattopadhyay, “Role of cholesterol in the function and organization of G-protein coupled receptors,” Progress in Lipid Research, vol. 45, no. 4, pp. 295–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. D. Paila and A. Chattopadhyay, “Membrane cholesterol in the function and organization of G-protein coupled receptors,” Sub-Cellular Biochemistry, vol. 51, pp. 439–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Oates and A. Watts, “Uncovering the intimate relationship between lipids, cholesterol and GPCR activation,” Current Opinion in Structural Biology, vol. 21, no. 6, pp. 802–807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Inagaki, R. Ghirlando, J. F. White, J. Gvozdenovic-Jeremic, J. K. Northup, and R. Grisshammer, “Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid,” Journal of Molecular Biology, vol. 417, no. 1-2, pp. 95–111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Alemany, J. S. Perona, J. M. Sánchez-Dominguez et al., “G protein-coupled receptor systems and their lipid environment in health disorders during aging,” Biochimica et Biophysica Acta—Biomembranes, vol. 1768, no. 4, pp. 964–975, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Kirilovsky and M. Schramm, “Delipidation of a β-adrenergic receptor preparation and reconstitution by specific lipids,” The Journal of Biological Chemistry, vol. 258, no. 11, pp. 6841–6849, 1983. View at Google Scholar · View at Scopus
  48. K. Simons and E. Ikonen, “How cells handle cholesterol,” Science, vol. 290, no. 5497, pp. 1721–1726, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. O. G. Mouritsen and M. J. Zuckermann, “What's so special about cholesterol?” Lipids, vol. 39, no. 11, pp. 1101–1113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Xu and E. London, “The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation,” Biochemistry, vol. 39, no. 5, pp. 843–849, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Mukherjee and F. R. Maxfield, “Membrane domains,” Annual Review of Cell and Developmental Biology, vol. 20, pp. 839–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Lingwood and K. Simons, “Lipid rafts as a membrane-organizing principle,” Science, vol. 327, no. 5961, pp. 46–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Chaudhuri and A. Chattopadhyay, “Transbilayer organization of membrane cholesterol at low concentrations: implications in health and disease,” Biochimica et Biophysica Acta, vol. 1808, no. 1, pp. 19–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Simons and G. van Meer, “Lipid sorting in epithelial cells,” Biochemistry, vol. 27, no. 17, pp. 6197–6202, 1988. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Simons and D. Toomre, “Lipid rafts and signal transduction,” Nature Reviews Molecular Cell Biology, vol. 1, no. 1, pp. 31–39, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. T. J. Pucadyil and A. Chattopadhyay, “Cholesterol: a potential therapeutic target in Leishmania infection?” Trends in Parasitology, vol. 23, no. 2, pp. 49–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Chattopadhyay and M. Jafurulla, “Role of membrane cholesterol in leishmanial infection,” Advances in Experimental Medicine and Biology, vol. 749, pp. 201–213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Roy, G. A. Kumar, M. Jafurulla, C. Mandal, and A. Chattopadhyay, “Integrity of the actin cytoskeleton of host macrophages is essential for Leishmania donovani infection,” Biochimica et Biophysica Acta, vol. 1838, no. 8, pp. 2011–2018, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. D. Paila and A. Chattopadhyay, “The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction?” Glycoconjugate Journal, vol. 26, no. 6, pp. 711–720, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. A. G. Lee, “Biological membranes: the importance of molecular detail,” Trends in Biochemical Sciences, vol. 36, no. 9, pp. 493–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. D. Paila, S. Tiwari, and A. Chattopadhyay, “Are specific nonannular cholesterol binding sites present in G-protein coupled receptors?” Biochimica et Biophysica Acta, vol. 1788, no. 2, pp. 295–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. A. C. Simmonds, J. M. East, O. T. Jones, E. K. Rooney, J. McWhirter, and A. G. Lee, “Annular and non-annular binding sites on the (Ca2+ + Mg2+)-ATPase,” Biochimica et Biophysica Acta: Biomembranes, vol. 693, no. 2, pp. 398–406, 1982. View at Publisher · View at Google Scholar · View at Scopus
  63. O. T. Jones and M. G. McNamee, “Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor,” Biochemistry, vol. 27, no. 7, pp. 2364–2374, 1988. View at Publisher · View at Google Scholar · View at Scopus
  64. A. G. Lee, “Lipid-protein interactions in biological membranes: a structural perspective,” Biochimica et Biophysica Acta, vol. 1612, no. 1, pp. 1–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. A. G. Lee, J. M. East, O. T. Jones, J. McWhirter, E. K. Rooney, and A. C. Simmonds, “Interaction of fatty acids with the calcium-magnesium ion dependent adenosinetriphosphatase from sarcoplasmic reticulum,” Biochemistry, vol. 21, no. 25, pp. 6441–6446, 1982. View at Publisher · View at Google Scholar · View at Scopus
  66. T. J. Pucadyil and A. Chattopadhyay, “Cholesterol modulates ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus,” Biochimica et Biophysica Acta—Biomembranes, vol. 1663, no. 1-2, pp. 188–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. T. J. Pucadyil, S. Shrivastava, and A. Chattopadhyay, “The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin1A receptor,” Biochemical and Biophysical Research Communications, vol. 320, no. 2, pp. 557–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. T. J. Pucadyil and A. Chattopadhyay, “Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors,” Biochimica et Biophysica Acta, vol. 1714, no. 1, pp. 35–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. T. J. Pucadyil, S. Shrivastava, and A. Chattopadhyay, “Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin1A receptors,” Biochemical and Biophysical Research Communications, vol. 331, no. 2, pp. 422–427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. D. Paila, T. J. Pucadyil, and A. Chattopadhyay, “The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin1A receptor,” Molecular Membrane Biology, vol. 22, no. 3, pp. 241–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. D. Paila, M. R. V. S. Murty, M. Vairamani, and A. Chattopadhyay, “Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome,” Biochimica et Biophysica Acta, vol. 1778, no. 6, pp. 1508–1516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Shrivastava, T. J. Pucadyil, Y. D. Paila, S. Ganguly, and A. Chattopadhyay, “Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin1A receptors,” Biochemistry, vol. 49, no. 26, pp. 5426–5435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. D. Paila, E. Jindal, S. K. Goswami, and A. Chattopadhyay, “Cholesterol depletion enhances adrenergic signaling in cardiac myocytes,” Biochimica et Biophysica Acta—Biomembranes, vol. 1808, no. 1, pp. 461–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Zocher, C. Zhang, S. G. F. Rasmussen, B. K. Kobilka, and D. J. Müller, “Cholesterol increases kinetic, energetic,and mechanical stability of the human β2-adrenergic receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 50, pp. E3463–E3472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. T. J. Pucadyil, S. Kalipatnapu, and A. Chattopadhyay, “The serotonin1A receptor: a representative member of the serotonin receptor family,” Cellular and Molecular Neurobiology, vol. 25, no. 3-4, pp. 553–580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. C. P. Müller, R. J. Carey, J. P. Huston, and M. A. de Souza Silva, “Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors,” Progress in Neurobiology, vol. 81, no. 3, pp. 133–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Kalipatnapu and A. Chattopadhyay, “Membrane organization and function of the serotonin1A receptor,” Cellular and Molecular Neurobiology, vol. 27, no. 8, pp. 1097–1116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Blier and N. M. Ward, “Is there a role for 5-HT1A agonists in the treatment of depression?” Biological Psychiatry, vol. 53, no. 3, pp. 193–203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. G. Griebel, “5-HT(1A) receptor blockers as potential drug candidates for the treatment of anxiety disorders,” Drug News and Perspectives, vol. 12, no. 8, pp. 484–490, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Celada, A. Bortolozzi, and F. Artigas, “Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research,” CNS Drugs, vol. 27, no. 9, pp. 703–716, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Singh, Y. D. Paila, and A. Chattopadhyay, “Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin1A receptor: implications in SLOS,” Biochemical and Biophysical Research Communications, vol. 358, no. 2, pp. 495–499, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Chattopadhyay, Y. D. Paila, M. Jafurulla et al., “Differential effects of cholesterol and 7-dehydrocholesterol on ligand binding of solubilized hippocampal serotonin1A receptors: implications in SLOS,” Biochemical and Biophysical Research Communications, vol. 363, no. 3, pp. 800–805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Singh, R. Saxena, Y. D. Paila, M. Jafurulla, and A. Chattopadhyay, “Differential effects of cholesterol and desmosterol on the ligand binding function of the hippocampal serotonin1A receptor: implications in desmosterolosis,” Biochimica et Biophysica Acta, vol. 1788, no. 10, pp. 2169–2173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Prasad, P. Singh, and A. Chattopadhyay, “Effect of capsaicin on ligand binding activity of the hippocampal serotonin1A receptor,” Glycoconjugate Journal, vol. 26, no. 6, pp. 733–738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. J. J. Ruprecht, T. Mielke, R. Vogel, C. Villa, and G. F. X. Schertler, “Electron crystallography reveals the structure of metarhodopsin I,” The EMBO Journal, vol. 23, no. 18, pp. 3609–3620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Warne, R. Moukhametzianov, J. G. Baker et al., “The structural basis for agonist and partial agonist action on a β1-adrenergic receptor,” Nature, vol. 469, no. 7329, pp. 241–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. W. Liu, E. Chun, A. A. Thompson et al., “Structural basis for allosteric regulation of GPCRS by sodium ions,” Science, vol. 337, no. 6091, pp. 232–236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Gimpl, “Cholesterol-protein interaction: methods and cholesterol reporter molecules,” Sub-cellular biochemistry, vol. 51, pp. 1–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Li and V. Papadopoulos, “Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern,” Endocrinology, vol. 139, no. 12, pp. 4991–4997, 1998. View at Google Scholar · View at Scopus
  90. R. M. Epand, “Cholesterol and the interaction of proteins with membrane domains,” Progress in Lipid Research, vol. 45, no. 4, pp. 279–294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. M. S. Brown and J. L. Goldstein, “A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11041–11048, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. P. E. Kuwabara and M. Labouesse, “The sterol-sensing domain: multiple families, a unique role?” Trends in Genetics, vol. 18, no. 4, pp. 193–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. C. J. Baier, J. Fantini, and F. J. Barrantes, “Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor,” Scientific Reports, vol. 1, article 69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Oddi, E. Dainese, F. Fezza et al., “Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor,” Journal of Neurochemistry, vol. 116, no. 5, pp. 858–865, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. J. C. M. Holthuis, T. Pomorski, R. J. Raggers, H. Sprong, and G. van Meer, “The organizing potential of sphingolipids in intracellular membrane transport,” Physiological Reviews, vol. 81, no. 4, pp. 1689–1723, 2001. View at Google Scholar · View at Scopus
  96. Y. A. Hannun and L. M. Obeid, “Principles of bioactive lipid signalling: lessons from sphingolipids,” Nature Reviews Molecular Cell Biology, vol. 9, no. 2, pp. 139–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. R. E. Brown, “Sphingolipid organization in biomembranes: what physical studies of model membranes reveal,” Journal of Cell Science, vol. 111, no. 1, pp. 1–9, 1998. View at Google Scholar · View at Scopus
  98. B. Ramstedt and J. P. Slotte, “Sphingolipids and the formation of sterol-enriched ordered membrane domains,” Biochimica et Biophysica Acta: Biomembranes, vol. 1758, no. 12, pp. 1945–1956, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Masserini and D. Ravasi, “Role of sphingolipids in the biogenesis of membrane domains,” Biochimica et Biophysica Acta, vol. 1532, no. 3, pp. 149–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Jacobson, O. G. Mouritsen, and R. G. W. Anderson, “Lipid rafts: at a crossroad between cell biology and physics,” Nature Cell Biology, vol. 9, no. 1, pp. 7–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Ganguly and A. Chattopadhyay, “Cholesterol depletion mimics the effect of cytoskeletal destabilization on membrane dynamics of the serotonin1A receptor: a zFCS study,” Biophysical Journal, vol. 99, no. 5, pp. 1397–1407, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. B. Sjögren and P. Svenningsson, “Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells,” Acta Physiologica, vol. 190, no. 1, pp. 47–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Jafurulla, T. J. Pucadyil, and A. Chattopadhyay, “Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors,” Biochimica et Biophysica Acta, vol. 1778, no. 10, pp. 2022–2025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. D. Paila, S. Ganguly, and A. Chattopadhyay, “Metabolic depletion of sphingolipids impairs ligand binding and signaling of human serotonin1A receptors,” Biochemistry, vol. 49, no. 11, pp. 2389–2397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Ganguly, Y. D. Paila, and A. Chattopadhyay, “Metabolic depletion of sphingolipids enhances the mobility of the human serotonin1A receptor,” Biochemical and Biophysical Research Communications, vol. 411, no. 1, pp. 180–184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Singh and A. Chattopadhyay, “Removal of sphingomyelin headgroup inhibits the ligand binding function of hippocampal serotonin1A receptors,” Biochemical and Biophysical Research Communications, vol. 419, no. 2, pp. 321–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Singh, Y. D. Paila, and A. Chattopadhyay, “Role of glycosphingolipids in the function of human serotonin1A receptors,” Journal of Neurochemistry, vol. 123, no. 5, pp. 716–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Chattopadhyay, Y. D. Paila, S. Shrivastava, S. Tiwari, P. Singh, and J. Fantini, “Sphingolipid-binding domain in the serotonin1A receptor,” Advances in Experimental Medicine and Biology, vol. 749, pp. 279–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Shanti and A. Chattopadhyay, “A new paradigm in the functioning of G-protein-coupled receptors,” Current Science, vol. 79, pp. 402–403, 2000. View at Google Scholar
  110. M. J. Lohse, “Dimerization in GPCR mobility and signaling,” Current Opinion in Pharmacology, vol. 10, no. 1, pp. 53–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. K. Palczewski, “Oligomeric forms of G protein-coupled receptors (GPCRs),” Trends in Biochemical Sciences, vol. 35, no. 11, pp. 595–600, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. L. Albizu, M. Cottet, M. Kralikova et al., “Time-resolved FRET between GPCR ligands reveals oligomers in native tissues,” Nature Chemical Biology, vol. 6, no. 8, pp. 587–594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. G. Milligan, “The role of dimerisation in the cellular trafficking of G-protein-coupled receptors,” Current Opinion in Pharmacology, vol. 10, no. 1, pp. 23–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. R. Panetta and M. T. Greenwood, “Physiological relevance of GPCR oligomerization and its impact on drug discovery,” Drug Discovery Today, vol. 13, no. 23-24, pp. 1059–1066, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. J. González-Maeso, R. L. Ang, T. Yuen et al., “Identification of a serotonin/glutamate receptor complex implicated in psychosis,” Nature, vol. 452, no. 7183, pp. 93–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. V. Casadó, A. Cortés, J. Mallol et al., “GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers?” Pharmacology and Therapeutics, vol. 124, no. 2, pp. 248–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Ganguly, A. H. A. Clayton, and A. Chattopadhyay, “Organization of higher-order oligomers of the serotonin1A receptor explored utilizing homo-FRET in live cells,” Biophysical Journal, vol. 100, no. 2, pp. 361–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. D. Paila, M. Kombrabail, G. Krishnamoorthy, and A. Chattopadhyay, “Oligomerization of the serotonin1A receptor in live cells: a time-resolved fluorescence anisotropy approach,” The Journal of Physical Chemistry B, vol. 115, no. 39, pp. 11439–11447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. J. R. James, M. I. Oliveira, A. M. Carmo, A. Iaboni, and S. J. Davis, “A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer,” Nature Methods, vol. 3, no. 12, pp. 1001–1006, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. B. H. Meyer, J.-M. Segura, K. L. Martinez et al., “FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2138–2143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. A. H. A. Clayton and A. Chattopadhyay, “Taking care of bystander FRET in a crowded cell membrane environment,” Biophysical Journal, vol. 106, no. 6, pp. 1227–1228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Tramier, T. Piolot, I. Gautier et al., “Homo-FRET versus hetero-FRET to probe homodimers in living cells,” Methods in Enzymology, vol. 360, pp. 580–597, 2003. View at Publisher · View at Google Scholar · View at Scopus
  123. L. W. Runnels and S. F. Scarlata, “Theory and application of fluorescence homotransfer to melittin oligomerization,” Biophysical Journal, vol. 69, no. 4, pp. 1569–1583, 1995. View at Publisher · View at Google Scholar · View at Scopus
  124. E. K. L. Yeow and A. H. A. Clayton, “Enumeration of oligomerization states of membrane proteins in living cells by homo-FRET spectroscopy and microscopy: theory and application,” Biophysical Journal, vol. 92, no. 9, pp. 3098–3104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. T. J. Pucadyil, S. Kalipatnapu, K. G. Harikumar, N. Rangaraj, S. S. Karnik, and A. Chattopadhyay, “G-protein-dependent cell surface dynamics of the human serotonin1A receptor tagged to yellow fluorescent protein,” Biochemistry, vol. 43, no. 50, pp. 15852–15862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Martin, C. G. Dotti, and M. D. Ledesma, “Brain cholesterol in normal and pathological aging,” Biochimica et Biophysica Acta, vol. 1801, no. 8, pp. 934–944, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. A. M. Stranahan, R. G. Cutler, C. Button, R. Telljohann, and M. P. Mattson, “Diet-induced elevations in serum cholesterol are associated with alterations in hippocampal lipid metabolism and increased oxidative stress,” Journal of Neurochemistry, vol. 118, no. 4, pp. 611–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. J. A. Allen and B. L. Roth, “Strategies to discover unexpected targets for drugs active at G protein-coupled receptors,” Annual Review of Pharmacology and Toxicology, vol. 51, pp. 117–144, 2011. View at Publisher · View at Google Scholar · View at Scopus